Patent Foramen Ovale: Story Closed?

The optimal treatment strategy for secondary prevention in patients with cryptogenic stroke and patent foramen ovale (PFO) has been a matter of controversy for decades. After three randomized trials failed to show a benefit of closure with an excess of complications in the interventional arm, two la...

Full description

Bibliographic Details
Main Authors: Martin Köhrmann, Peter D. Schellinger, Georgios Tsivgoulis, Thorsten Steiner
Format: Article
Language:English
Published: Korean Stroke Society 2019-01-01
Series:Journal of Stroke
Subjects:
Online Access:http://www.j-stroke.org/upload/pdf/jos-2018-03097.pdf